Review Article
Volume 8 Issue 11 - 2021
Mindfulness Miscellany: Therapeutic Indications and Contraindications of Various Meditation Techniques on Specific Human Biomarkers and Conditions, Including Potential Immunomodulation in COVID-19
Nicholas A Kerna1,2*, ND Victor Carsrud3, Joseph Anderson II4, John V Flores5,6, Sahalia Rashid7, Hilary M Holets5,6 and Sudeep Chawla7
1SMC-Medical Research, Thailand
2First InterHealth Group, Thailand
3Lakeline Wellness Center, USA
4International Institute of Original Medicine, USA
5Beverly Hills Wellness Surgical Institute, USA
6Orange Partners Surgicenter, USA
7Chawla Health & Research, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: September 29, 2021; Published: October 26, 2021


Meditation has been practiced by specific individuals and groups since ancient times, providing not only spiritual insights but also health benefits. Much more recently, meditation has been investigated for such health-promoting effects and disorder prevention. Transcendental meditation (TM) is the most notable and practiced form of meditation, spanning continents, cultures, and religious affiliations. TM was introduced to the Western world by the revered Maharishi Mahesh Yogi in the mid-twentieth century. Over subsequent decades, the practice of TM has spread globally. Its popularity is based primarily on its ease of learning, being unaffiliated with any religion or philosophy, the relatively short time required each day for its effective practice (two times per day, twenty minutes per session), near-global access for the novice to learn the meditation technique, and the frequently occurring, immediate benefits noted by new practitioners and sustained personal and social benefits in established practitioners.

This review covers a miscellany of meditation topics, highlighting the researched effects of TM on reducing inflammation, in establishing and maintaining healthy blood pressure, its adjuvant application for cancer patients, its potential in COVID-19, in regulating plasma glucose levels and lipid profiles (particularly in the diabetic and overweight and obese populations), as an effective immunomodulator, in enhancing longevity, accelerating wound repair—as well as TM’s overall safety and relatively rare adverse events from practicing TM. TM is highlighted as it is the most widely researched meditation techniques globally.

Keywords: Anti-Inflammatory Blood Pressure; Cancer; COVID-19; Immunomodulation; Lipid Profile; Longevity; Plasma Glucose; Psychodermatology


  1. Arias AJ., et al. “Systematic review of the efficacy of meditation techniques as treatments for medical illness”. Journal of Alternative and Complementary Medicine8 (2006): 817-832.
  2. Fortney L and Taylor M. “Meditation in medical practice: a review of the evidence and practice”. Primary Care1 (2010): 81-90.
  3. Rakicevic M. “27 Meditation Statistics for Your Well-Being in (2021).
  4. Meditation: In-Depth.
  5. Some other types of meditation.
  6. Behavior: The TM craze: 40 minutes to bliss". Time. 1975-10-13.
  7. Needleman J. “Transcendental Meditation". The New Rel1st edition.)”. Garden City N.Y.: Doubleday (1970): 132-147.
  8. Mahesh Yogi M. “The Science of Being and Art of Living”. Meridian Publishing (1963).
  9. Roth R. Transcendental Meditation. New York: Primus (1994).
  10. The story of transcendental meditation.
  11. Morris B. “Maharishi's Vedic Science and Technology: The Only Means to Create World Peace”. Modern Science and Vedic Science Journal1-2 (1992): 200.
  12. Feloni R. “History of transcendental meditation” (2016).
  13. Wallace RK. “Physiological effects of Transcendental Meditation”. Science 167 (1970): 1751-1754.
  14. Unsolved: Transcendental Meditation technique.
  15. Goldstein CM., et al. “Current Perspectives on the Use of Meditation to Reduce Blood Pressure”. International Journal of Hypertension (2012): 578397.
  16. Cleveland Clinic. Meditation (2018).
  17. Jang JH., et al. “Effects of Mind-Body Training on Cytokines and Their Interactions with Catecholamines”. Psychiatry Investigation4 (2017): 483-490.
  18. Jevning R., et al. “Behavioral alteration of plasma phenylalanine concentration”. Physiology and Behavior5 (1977): 611-614.
  19. Rainforth MV., et al. “Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis”. Current Hypertension Reports 9 (2007): 520-528.
  20. Walton KG., et al. “Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention”. Journal of Behavioral Medicine 28 (2002): 106-123.
  21. Ooi SL., et al. “Transcendental meditation for lowering blood pressure: An overview of systematic reviews and meta-analyses”. Complementary Therapies in Medicine 34 (2017): 26-34.
  22. Schneider R., et al. “A randomized controlled trial of stress reduction for hypertension in older African Americans”. Hypertension (1995): 26820-26827.
  23. Alexander CN., et al. “A trial of stress reduction for hypertension in older African Americans, II: sex and risk factor subgroup analysis”. Hypertension (1996): 28228-28237.
  24. Barnes VA., et al. “Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure”. Journal of Psychosomatic Research4 (2001): 597-605.
  25. Anderson JW., et al. “Blood pressure response to transcendental meditation: a meta-analysis”. American Journal of Hypertension3 (2008): 310-316.
  26. Brook RD., et al. “Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association”. Hypertension6 (2013): 1360-1383.
  27. Wenneberg SR., et al. “A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure”. International Journal of Neuroscience 89 (1997): 15-28.
  28. Canter PH and Ernst E. “Insufficient evidence to conclude whether or not Transcendental Meditation decreases blood pressure: results of a systematic review of randomized clinical trials”. Journal of Hypertension 22 (2004): 2049-2054.
  29. Hartley L., et al. “Transcendental meditation for the primary prevention of cardiovascular disease”. The Cochrane Database of Systematic Reviews 12 (2014): CD010359.
  30. Cancer Research UK (2019).
  31. Nidich SI., et al. “A randomized controlled trial of the effects of transcendental meditation on quality of life in older breast cancer patients”. Integrative Cancer Therapies3 (2009): 228-234.
  32. Mahone MC., et al. “fMRI during Transcendental Meditation practice”. Brain and Cognition 123 (2018): 30-33.
  33. Infante JR., et al. “Levels of immune cells in transcendental meditation practitioners”. The International Journal of Yoga Therapy2 (2014): 147-151.
  34. Orme-Johnson D. “Medical care utilization and the transcendental meditation program”. Psychosomatic Medicine5 (1987): 493-507.
  35. Bay R and Bay F. “Combined Therapy Using Acupressure Therapy, Hypnotherapy, and Transcendental Meditation versus Placebo in Type 2 Diabetes”. Journal of Acupuncture and Meridian Studies3 (2011): 183-186.
  36. Paul-Labrador M., et al. “Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease”. Archives of Internal Medicine11 (2006): 1218-1224.
  37. Mills PJ., et al. “Beta-adrenergic receptor sensitivity in subjects practicing transcendental meditation”. Journal of Psychosomatic Research1 (1990): 29-33.
  38. Schneider RH., et al. “Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension”. The American Journal of Cardiology9 (2005): 1060-1064.
  39. Alexander CN., et al. “Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly”. Journal of Personality and Social Psychology6 (1989): 950-964.
  40. Cooper MJ and Aygen MM. “Transcendental Meditation in the management of hypercholesterolemia”. Journal of Human Stress4 (1979): 24-27.
  41. Cooper MJ and Aygen MM. “Effect of Transcendental Meditation on serum cholesterol and blood pressure”. Harefuah The Israel Medical Association Journal1 (1978): 1-2.
  42. Shenoi SD and Prabhu SS. “Psychodermatology: An Indian perspective”. Clinics in Dermatology6 (2018): 737-742.
  43. Farias M., et al. “Adverse events in meditation practices and meditation-based therapies: a systematic review”. Acta Psychiatrica Scandinavica5 (2020): 374-393.
  44. Lindahl JR., et al. “The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists”. PLoS One 12 (2017): e0176239.
  45. Van Dam NT., et al. “Reiterated concerns and further challenges for mindfulness and meditation research: a reply to Davidson and Dahl”. Perspectives on Psychological Science - SAGE Journals 13 (2018): 66-69.
  46. Persinger MA. “Transcendental Meditation (TM) and General Meditation are Associated with Enhanced Complex Partial Epileptic-Like Signs: Evidence for “Cognitive” Kindling?” Perceptual and Motor Skills1 (1993): 80-82.
  47. Otis L. “Adverse effects of transcendental meditation”. In: D Shapiro, R Walsh, editors. Meditation: classic and contemporary perspectives. New York, NY: Aldine (1984): 201-208.
  48. Vieten C., et al. “Future directions in meditation research: Recommendations for expanding the field of contemplative science”. PLoS One 13 (2018): e0205740.
  49. Persinger MA. “Striking EEG profiles from single episodes of glossolalia and transcendental meditation”. Perceptual and Motor Skills 58 (1984): 127-133.
  50. Rodríguez FM. “Estudio sobre “Efectos Adversos” Relacionados con la Meditación Study about Meditation Related “Side Effects”. Journal of Transpersonal Research 7 (2015): 188-198.
Citation: Kerna NA, Carsrud NDV, Anderson II J, Flores JV, Rashid S, Holets HM, Chawla S. “Mindfulness Miscellany: Therapeutic Indications and Contraindications of Various Meditation Techniques on Specific Human Biomarkers and Conditions, Including Potential Immunomodulation in COVID-19”. EC Cardiology 8.11 (2021): 06-15.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 13, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.